Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3995089rdf:typepubmed:Citationlld:pubmed
pubmed-article:3995089lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3995089lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:3995089lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:3995089lifeskim:mentionsumls-concept:C0014139lld:lifeskim
pubmed-article:3995089lifeskim:mentionsumls-concept:C0019134lld:lifeskim
pubmed-article:3995089lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:3995089pubmed:issue2lld:pubmed
pubmed-article:3995089pubmed:dateCreated1985-7-24lld:pubmed
pubmed-article:3995089pubmed:abstractTextBinding of heparin and low molecular weight heparin fragments (CY 222, Mr range 1500-8000) to human vascular endothelial cells was studied. Primary culture of human umbilical vein endothelial cells and either 125I or 3H-labeled heparin or [125I]CY 222 were used. Slow, saturable and specific binding was found. No other tested glycosaminoglycan, excepting a highly sulfated heparan fraction, was able to compete for heparin binding. Two groups of binding sites for [3H]heparin could be distinguished: one with high affinity (Kd = 0.12 microM) and another with lower affinity (Kd = 1.37 microM) and a relative large capacity of binding (1.16 X 10(7) molecules/cell) was calculated. The Kd for unlabeled heparin, as calculated from competition experiments, was 0.23 microM. Much lower affinity was calculated for unlabeled low molecular weight heparin fragments CY 222 (Kd = 4.3 microM) from competition experiments with [125I]CY 222. The binding reversibility was only partial for unfractionated heparin. Even by chasing with unlabeled compound, a fraction of 25-30% was not dissociable from endothelial cells. This fraction was much lower if incubation was carried out at 4 degrees C. The addition of basic proteins (histones) to the incubation medium greatly enhanced the undissociable binding at 37 degrees C, but not at 4 degrees C. The undissociable fraction of heparin was not available to degradation by purified microbial heparinase. These results suggest that a fraction of bound heparin is internalized by the vascular endothelium.lld:pubmed
pubmed-article:3995089pubmed:languageenglld:pubmed
pubmed-article:3995089pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3995089pubmed:citationSubsetIMlld:pubmed
pubmed-article:3995089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3995089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3995089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3995089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3995089pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3995089pubmed:statusMEDLINElld:pubmed
pubmed-article:3995089pubmed:monthMaylld:pubmed
pubmed-article:3995089pubmed:issn0006-3002lld:pubmed
pubmed-article:3995089pubmed:authorpubmed-author:BârzuTTlld:pubmed
pubmed-article:3995089pubmed:authorpubmed-author:CaenJJlld:pubmed
pubmed-article:3995089pubmed:authorpubmed-author:TobelemGGlld:pubmed
pubmed-article:3995089pubmed:authorpubmed-author:PetitouMMlld:pubmed
pubmed-article:3995089pubmed:authorpubmed-author:MolhoPPlld:pubmed
pubmed-article:3995089pubmed:issnTypePrintlld:pubmed
pubmed-article:3995089pubmed:day30lld:pubmed
pubmed-article:3995089pubmed:volume845lld:pubmed
pubmed-article:3995089pubmed:ownerNLMlld:pubmed
pubmed-article:3995089pubmed:authorsCompleteYlld:pubmed
pubmed-article:3995089pubmed:pagination196-203lld:pubmed
pubmed-article:3995089pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:meshHeadingpubmed-meshheading:3995089-...lld:pubmed
pubmed-article:3995089pubmed:year1985lld:pubmed
pubmed-article:3995089pubmed:articleTitleBinding and endocytosis of heparin by human endothelial cells in culture.lld:pubmed
pubmed-article:3995089pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3995089pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3995089lld:pubmed